Key result
T2DM in ACS is linked to a ~292% higher rate of multi-vascular coronary lesions.
Why the study?
Patients with T2DM face twice the risk of CAD and markedly higher myocardial infarction mortality, prompting evaluation of how T2DM impacts clinical course, diagnostic findings, prognosis, and treatment strategy in ACS.
Does type 2 diabetes mellitus worsen the clinical course, cardiac remodeling, and prognosis in patients with acute coronary syndrome?
Observational (n=103)
Open-label
No
Does type 2 diabetes mellitus worsen the clinical course, cardiac remodeling, and prognosis in patients with acute coronary syndrome?
Absolute Event Rate: 56% vs 14.3%
p-value: p=<0.05
Type 2 diabetes mellitus in patients with acute coronary syndrome is associated with more severe multi-vessel disease, greater myocardial necrosis, adverse cardiac remodeling, and a higher risk of cardiac death.
Supports diabetes-multivessel link in ACS; hypothesis-generating for remodeling and prognosis, needing prospective confirmation.
Background. Patients with type 2 diabetes mellitus (T2DM) have a two-fold risk of coronary artery disease (CAD), and their myocardial infarction-associated mortality is 2–4 times higher compared to patients with intact carbohydrate metabolism. The purpose of the study: to determine the impact of type 2 diabetes on the severity of clinical course, changes in laboratory and instrumental findings, the prognosis and treatment strategy selection in patients with acute coronary syndrome (ACS). Materials and methods. We have examined 75 patients with ACS, which has developed on the background of T2DM (the main group), and 28 patients with ACS without T2DM (the control group). ACS with T2DM was substantially more frequent (84 % of cases) in young to middle-aged males (up to 60 years of age) who predominated compared to female patients in a 4.8 : 1 ratio. It was typical for these patients to have frequent comorbid conditions, namely: hypertension (94.7 %), metabolic syndrome (85.3 %), chronic kidney disease (30.7 %), chronic obstructive pulmonary disease (29.3 %), thyroid dysfunction (22.7 %), and such CAD risk factors (and their combinations in 89.3 % of cases) as atherogenic dyslipidemia (96.0 %), tobacco smoking (34.7 %), excessive alcohol use (32.0 %), family history of CAD and T2DM (29.3 and 61.3 % of patients, respectively). Results. The characteristic clinical feature in a patient with ACS and T2DM is a severe condition, which is due to a combined multi-vascular involvement of coronary arteries (which is 10.5 times more frequent in these patients) and larger volumes of myocardial necrosis. Such individuals have more pronounced manifestations of necrosis-resorption syndrome, a significant increase in left ventricular myocardial mass and volume due to an increase in diastolic and systolic dimensions, which suggests hypertrophy and cardiac remodeling with impaired systolic function (ejection fraction of less than 50 %) and impaired diastolic function; the latter is considered an impairment of relaxation processes. Conclusions. The clinical portrait of patients with ACS developed on the background of type 2 diabetes is characterized by the following features: men under 60 years of age with comorbid conditions and multiple risk factors for coronary artery disease, multivessel and hemodynamically severe coronary lesions (more than 33 points on the SYNTAX scale), large volume of myocardial necrosis, which determines the atypicality and severity of the disease, high grade of heart failure, a significantly higher incidence of life-threatening complications, and a high risk (over 160 points on GRACE score) of cardiac death.
No takes yet. Share an insight, caveat, or question.
Швед et al. (2024) conducted an observational in Acute coronary syndrome (STEMI) (n=103). Type 2 diabetes mellitus vs. Without type 2 diabetes mellitus was evaluated on Multi-vascular coronary artery lesions (p=<0.05). Type 2 diabetes mellitus in patients with acute coronary syndrome was associated with a significantly higher rate of multi-vascular coronary lesions (56.0% vs 14.3%) compared to patients without diabetes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: